Detail Information
Publications
A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's diseaseBruce Yacyshyn
Rochester Institute for Digestive Diseases and Science, Rochester, New York, USA
Clin Gastroenterol Hepatol 5:215-20. 2007....
